| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.093 | 0.08 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.086 | 0.08 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.049 | 0.08 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.09 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.09 |